'Molecular weight heparin' presentation slideshows

Chest Pain/ MI/Shock

782 views • 74 slides

Peri-operative Management and DVT Prophylaxis

904 views • 45 slides

EVALUATION OF RECURRENT PREGNANCY LOSS An Evidence Based Approach

EVALUATION OF RECURRENT PREGNANCY LOSS An Evidence Based Approach. John A. Schnorr, M.D. Coastal Fertility Specialists Medical University of South Carolina. Recurrent Pregnancy Loss Incidence of Miscarriages. 30 to 50% of all conceptions 15% of all clinically recognized pregnancies

908 views • 41 slides

612 views • 40 slides

Nov 21 st , 2011 Jaehyung (Gus) Cho, Ph.D . Assistant Professor Department of Pharmacology

Medical Pharmacology Drug Treatment of Thrombosis. Nov 21 st , 2011 Jaehyung (Gus) Cho, Ph.D . Assistant Professor Department of Pharmacology Tel: 312-355-5923 (Office: 5095 CoMRB ) Email: thromres@uic.edu. Anti-thrombotic agents I. Anti-coagulant agents II. Fibrinolytic agents

523 views • 36 slides

Prevalence of risk factors for VTE in hospitalized medical and surgical patients

COmparison of Methods for thromboembolic risk assessment with clinical Perceptions and AwareneSS in real life Surgical and Medical patients COMPASS study . Prevalence of risk factors for VTE in hospitalized medical and surgical patients . Unmet needs for VTE risk stratification.

514 views • 35 slides

Pulmonary embolism and anestheisa

Pulmonary embolism and anestheisa. Presented by R1 ???. Pulmonary embolism. Pre-operative Considerations -from blood clots, tumor cells, air, amniotic fluid, foreign material

1.1k views • 33 slides

ANTICOAGULANTS AND THROMBOLYTIC AGENTS

ANTICOAGULANTS AND THROMBOLYTIC AGENTS. I-Anticoagulants:. 1-HEPARIN. 2-Oral anticoagulants. 3-Antithrombin. Low molecular weight heparin Synthetic pentasaccharide inhibitors of factor Xa

920 views • 28 slides

Venous thromboembolism: reducing the risk

Venous thromboembolism: reducing the risk. Implementing NICE guidance. January 2010. NICE clinical guideline 92. Updated guidance.

672 views • 25 slides

Spotlight Case December 2006

Spotlight Case December 2006. Hidden Heparins: HIT Happens. Source and Credits. This presentation is based on the December 2006 AHRQ WebM&M Spotlight Case See the full article at http://webmm.ahrq.gov CME credit is available through the Web site

419 views • 24 slides

The Role of Thromboprophylaxis in Elective Spinal Surgery

The Role of Thromboprophylaxis in Elective Spinal Surgery. VA Elwell, N Koo Ng, D Horner & D Peterson Departments of Neurosurgery and Anaesthetics The Hammersmith Hospitals NHS Trust, Charing Cross Hospital Academic Health Science Centre, London, UK. Background. Background.

329 views • 21 slides

Portal Hypertension

Portal Hypertension. Mazen Hassanain. Causes. Cirrhosis Non-cirrhosis. Symptoms. Asymptomatic Complications G astroesophageal varices A scites Splenomegaly Underlying disease. Bleeding prevention.

495 views • 19 slides

Purpose

Comparison of bivalirudin versus heparin(s) during percutaneous coronary intervention in patients receiving prasugrel. Martial Hamon 1 , Steven Marso 2 , Sunil Rao 3 , Marco Valgimigli 4 , Freek Verheugt 5 , Anthony Gershlick 6 , Yamei Wang 8 , Gabriel Steg 7 , Efthymios Deliargyris 8

239 views • 13 slides

Presented at ACC 2003 Late Breaking Clinical Trials

A ggrastat- Phase of the AGGRASTAT to ZOCOR (A to Z) Trial Comparison of the safety and efficacy of unfractionated heparin versus enoxaparin in combination with tirofiban and aspirin in individuals who present with non-ST elevation acute coronary syndromes. Presented at ACC 2003

162 views • 4 slides